Margaret Anderson
Showing 16–18 of 18 transcripts.
- Milken Institute1h 0m
Bioscience Discoveries That Will Blow Your Mind
Jack Andraka, David Baltimore, Francis Collins, Tejal Desai, Aydogan Ozcan, Margaret Anderson
A panel of leading scientists including Jack Andraka, Tejal Desai, David Baltimore, and Francis Collins outlined breakthrough innovations in cancer detection, gene therapy, and nanotechnology while highlighting the transformative potential of open-access data. Despite rapid advancements in genomic sequencing and portable diagnostics, experts warned of a critical decline in U.S. biomedical funding that is discouraging young researchers from pursuing high-risk scientific careers. The discussion concluded with calls to establish special grant programs for early-career innovators and to restore emphasis on curiosity-driven education to sustain future scientific progress.
- Milken Institute1h 3m
Impatient Patients: How Disease Organizations Are Accelerating Research
Margaret Anderson, Lou DiGennaro, Jonathan Simons, Gordon Gunn, Deborah Black, John Walsh
Representatives from Faster Cures and five major disease-focused nonprofits outlined how venture philanthropy and patient-led activism accelerate cures by de-risking early-stage research and navigating the "Valley of Death" between discovery and clinical application. Leaders from the Leukemia and Lymphoma Society, Prostate Cancer Foundation, and the Alpha-1 Foundation detailed strategic investments that generated massive financial leverage and established critical infrastructure, such as patient registries and rapid autopsy programs, to overcome funding gaps and accelerate trial recruitment. The panel concluded that sustainable progress requires aligning academia, industry, and regulators while empowering patients to actively define research priorities and drive policy changes for faster approvals and reimbursement.
- Milken Institute1h 7m
Precision Medicine, Custom Cures
Margaret Anderson, Mike Polini, Jim Greenwood, George Church, Retta Berry, Chris Austin
Led by former NIH Director Francis Collins and moderated by Margaret Anderson, a diverse panel of scientists, industry leaders, and patient advocates examined the critical gap between rapid advances in precision medicine sequencing and clinical deployment. While the discussion highlighted success stories like the Berry family's transition from a diagnostic odyssey to effective treatment and the rising adoption of gene therapies, it also exposed systemic bottlenecks in rare disease therapeutics, reimbursement models, and data silos that prevent timely translation of genetic discoveries into cures. The group concluded that realizing the full potential of this medical revolution requires structural healthcare reform, robust data-sharing frameworks, and a shift toward participatory medicine where patients actively drive their own health outcomes.